Abstract
DNA vaccines encoding replication-defective viruses are safer than inactivated or live attenuated viruses but may fail to stimulate an immune response sufficient for effective vaccination. We augment the protective capacity of a capsid-deleted flavivirus DNA vaccine by co-expressing the capsid protein from a separate promoter. In transfected cells, the capsid-deleted RNA transcript is replicated and translated to produce secreted virus-like particles lacking the nucleocapsid. This RNA is also packaged with the help of co-expressed capsid protein to form secreted single-round infectious particles (SRIPs) that deliver the RNA into neighboring cells. In SRIP-infected cells, the RNA is replicated again and produces additional virus-like particles, but in the absence of capsid RNA no SRIPs are formed and no further spread occurs. Compared with an otherwise identical construct that does not encode capsid, our vaccine offers better protection to mice after lethal West Nile virus infection. It also elicits virus-neutralizing antibodies in horses. This approach may enable vaccination against pathogenic flaviviruses other than West Nile virus.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Pugachev, K.V., Guirakhoo, F., Trent, D.W. & Monath, T.P. Traditional and novel approaches to flavivirus vaccines. Int. J. Parasitol. 33, 567–582 (2003).
Chang, G.J., Davis, B.S., Hunt, A.R., Holmes, D.A. & Kuno, G. Flavivirus DNA vaccines: current status and potential. Ann. NY Acad. Sci. 951, 272–285 (2001).
Phillpotts, R.J., Venugopal, K. & Brooks, T. Immunisation with DNA polynucleotides protects mice against lethal challenge with St. Louis encephalitis virus. Arch. Virol. 141, 743–749 (1996).
Konishi, E., Yamaoka, M., Khin Sane, W., Kurane, I. & Mason, P.W. Induction of protective immunity against Japanese encephalitis in mice by immunization with a plasmid encoding Japanese encephalitis virus premembrane and envelope genes. J. Virol. 72, 4925–4930 (1998).
Colombage, G., Hall, R., Pavy, M. & Lobigs, M. DNA-based and alphavirus-vectored immunisation with prM and E proteins elicits long-lived and protective immunity against the flavivirus, Murray Valley encephalitis virus. Virology 250, 151–163 (1998).
Kochel, T. et al. Inoculation of plasmids expressing the dengue-2 envelope gene elicit neutralizing antibodies in mice. Vaccine 15, 547–552 (1997).
Aberle, J.H. et al. A DNA immunization model study with constructs expressing the tick-borne encephalitis virus envelope protein E in different physical forms. J. Immunol. 163, 6756–6761 (1999).
Davis, B.S. et al. West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays. J. Virol. 75, 4040–4047 (2001).
Hall, R.A. & Khromykh, A.A. West Nile virus vaccines. Expert Opin. Biol. Ther. 4, 1295–1305 (2004).
Anraku, I. et al. Kunjin virus replicon vaccine vectors induce protective CD8+ T-cell immunity. J. Virol. 76, 3791–3799 (2002).
Kofler, R.M. et al. Mimicking live flavivirus immunization with a noninfectious RNA vaccine. Proc. Natl. Acad. Sci. USA 101, 1951–1956 (2004).
Seregin, A. et al. Immunogenicity of West Nile virus infectious DNA and its noninfectious derivatives. Virology 356, 115–125 (2006).
Mason, P.W., Shustov, A.V. & Frolov, I. Production and characterization of vaccines based on flaviviruses defective in replication. Virology 351, 432–443 (2006).
Hall, R.A., Broom, A.K., Smith, D.W. & Mackenzie, J.S. The ecology and epidemiology of Kunjin virus. Curr. Top. Microbiol. Immunol. 267, 253–269 (2002).
Hall, R.A. et al. Loss of dimerisation of the nonstructural protein NS1 of Kunjin virus delays viral replication and reduces virulence in mice, but still allows secretion of NS1. Virology 264, 66–75 (1999).
Hall, R.A. et al. DNA vaccine coding for the full-length infectious Kunjin virus RNA protects mice against the New York strain of West Nile virus. Proc. Natl. Acad. Sci. USA 100, 10460–10464 (2003).
Co, M.D., Terajima, M., Cruz, J., Ennis, F.A. & Rothman, A.L. Human cytotoxic T lymphocyte responses to live attenuated 17D yellow fever vaccine: identification of HLA-B35-restricted CTL epitopes on nonstructural proteins NS1, NS2b, NS3, and the structural protein E. Virology 293, 151–163 (2002).
Raz, E. et al. Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. Proc. Natl. Acad. Sci. USA 91, 9519–9523 (1994).
Pertmer, T.M. et al. Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA. Vaccine 13, 1427–1430 (1995).
Castillo-Olivares, J. & Wood, J. West Nile virus infection of horses. Vet. Res. 35, 467–483 (2004).
Ng, T. et al. Equine vaccine for West Nile virus. Dev. Biol. (Basel) 114, 221–227 (2003).
Schlesinger, J.J., Brandriss, M.W., Putnak, J.R. & Walsh, E.E. Cell surface expression of yellow fever virus non-structural glycoprotein NS1: consequences of interaction with antibody. J. Gen. Virol. 71, 593–599 (1990).
Chung, K.M. et al. Antibodies against West Nile Virus nonstructural protein NS1 prevent lethal infection through Fc gamma receptor-dependent and -independent mechanisms. J. Virol. 80, 1340–1351 (2006).
Khromykh, A.A., Sedlak, P.L. & Westaway, E.G. cis- and trans-acting elements in flavivirus RNA replication. J. Virol. 74, 3253–3263 (2000).
Lindenbach, B.D. & Rice, C.M. trans-Complementation of yellow fever virus NS1 reveals a role in early RNA replication. J. Virol. 71, 9608–9617 (1997).
Twiddy, S.S. & Holmes, E.C. The extent of homologous recombination in members of the genus Flavivirus. J. Gen. Virol. 84, 429–440 (2003).
Monath, T.P. et al. Recombination and flavivirus vaccines: a commentary. Vaccine 23, 2956–2958 (2005).
Lindenbach, B.D. & Rice, C. Flaviviridae: the viruses and their replication. in Fields Virology. 4th edn. (eds. Knipe, D.M. & Howley, P.M.) 991–1041 (Lippincott Williams & Wilkins, Philadelphia, 2001).
Le, T.T. et al. Cytotoxic T cell polyepitope vaccines delivered by ISCOMs. Vaccine 19, 4669–4675 (2001).
Spaulding, A.C., Kurane, I., Ennis, F.A. & Rothman, A.L. Analysis of murine CD8(+) T-cell clones specific for the Dengue virus NS3 protein: flavivirus cross-reactivity and influence of infecting serotype. J. Virol. 73, 398–403 (1999).
Acknowledgements
We thank Jane Pollitt, Joanne Meers and Paul Mills (all from School of Veterinary Sciences, University of Queensland) for valuable assistance in designing and performing horse vaccination experiments; Wai Yuen Cheah, Kim Pham and Natalie Prow (University of Queensland) for assistance with mouse experiments and serological analysis of mouse and horse sera; Greg Smith, Alyssa Pyke and Bruce Harrower (all from Queensland Heath Forensic and Scientific Services) for generously providing PC3 animal facilities and logistical assistance for mouse challenge studies; and James Doecke (QIMR) for assistance with statistics.
Author information
Authors and Affiliations
Contributions
D.C. Chang designed experiments, performed the majority of the experiments, analyzed data and wrote the manuscript; W.J.L. designed experiments, immunized mice and analyzed data; I.A. designed, performed and analyzed ELISPOT assays; D.C. Clark assisted with mice experiments; C.C.P. provided veterinary expertise and supervised horse experiments; A.S. designed the ELISPOT assays and wrote the manuscript; R.A.H. designed animal experiments, analyzed data and wrote the manuscript; and A.A.K. generated the idea, designed and coordinated the research, analyzed data and wrote the manuscript.
Corresponding author
Supplementary information
Supplementary Text and Figures
Figures 1–4 (PDF 1394 kb)
Rights and permissions
About this article
Cite this article
Chang, D., Liu, W., Anraku, I. et al. Single-round infectious particles enhance immunogenicity of a DNA vaccine against West Nile virus. Nat Biotechnol 26, 571–577 (2008). https://doi.org/10.1038/nbt1400
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt1400
This article is cited by
-
Successful post-exposure prophylaxis of Ebola infected non-human primates using Ebola glycoprotein-specific equine IgG
Scientific Reports (2017)
-
Newcastle disease virus-vectored West Nile fever vaccine is immunogenic in mammals and poultry
Virology Journal (2016)
-
Japanese encephalitis virus replicon-based vaccine expressing enterovirus-71 epitope confers dual protection from lethal challenges
Journal of Biomedical Science (2015)
-
Induction of ebolavirus cross-species immunity using retrovirus-like particles bearing the Ebola virus glycoprotein lacking the mucin-like domain
Virology Journal (2012)
-
Recent progress in West Nile virus diagnosis and vaccination
Veterinary Research (2012)